It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

Host Keith Shaw and his expert guests discuss the latest technology news and trends happening in the industry. Watch new episodes twice each week or listen to the podcast here. In today’s 2-Minute ...